NDC 51672-5293

Ovide

Malathion

Ovide is a Topical Lotion in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Malathion.

Product ID51672-5293_f0a63cc5-d38b-45b2-8810-f9edcbbde2ce
NDC51672-5293
Product TypeHuman Prescription Drug
Proprietary NameOvide
Generic NameMalathion
Dosage FormLotion
Route of AdministrationTOPICAL
Marketing Start Date2014-01-31
Marketing CategoryANDA / ANDA
Application NumberANDA091559
Labeler NameTaro Pharmaceuticals U.S.A., Inc.
Substance NameMALATHION
Active Ingredient Strength0 g/mL
Pharm ClassesCholinesterase Inhibitors [MoA],Cholinesterase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51672-5293-4

1 BOTTLE in 1 CARTON (51672-5293-4) > 59 mL in 1 BOTTLE
Marketing Start Date2014-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51672-5293-4 [51672529304]

Ovide LOTION
Marketing CategoryANDA
Application NumberANDA091559
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-01-31

Drug Details

Active Ingredients

IngredientStrength
MALATHION.0005 g/mL

OpenFDA Data

SPL SET ID:945f46fa-4b79-49fd-a890-477f251e2164
Manufacturer
UNII

Pharmacological Class

  • Cholinesterase Inhibitors [MoA]
  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]
  • Cholinesterase Inhibitor [EPC]

Medicade Reported Pricing

51672529304 OVIDE 0.5% LOTION

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Ovide" or generic name "Malathion"

NDCBrand NameGeneric Name
51672-5276OVIDEMALATHION
51672-5293OvideMalathion
51672-5277MALATHIONMALATHION
51672-5294MalathionMalathion
68022-0001MalathionMalathion

Trademark Results [Ovide]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OVIDE
OVIDE
73789557 1583279 Live/Registered
GENDERM CORPORATION
1989-03-27
OVIDE
OVIDE
73460314 1374592 Dead/Cancelled
SYSECA-TEMPS REEL
1984-01-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.